BOSTON SCIENTIFIC CORPORATION Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest
BOSTON SCIENTIFIC CORPORATION (BSX) reported Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest of $12.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToNoncontrollingInterest · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$6.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$26.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was $16.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for fiscal 2025 was $12.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for fiscal 2024 was -$7.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for fiscal 2023 was -$10.00M.
- BOSTON SCIENTIFIC CORPORATION other comprehensive income (loss), before tax, portion attributable to noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 12 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $12.00M 10-K · filed 2026-02-17 | ||||
| 2024-12-31 | -$7.00M 10-K · filed 2026-02-17 | ||||
| 2024-03-31 | -$6.00M 10-Q · filed 2024-05-01 | -$32.00M derived: sum of 2 quarters · filed 2026-02-17 | -$16.00M derived: sum of 3 quarters · filed 2026-02-17 | -$16.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | -$26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$10.00M derived: sum of 2 quarters · filed 2026-02-17 | -$10.00M derived: sum of 3 quarters · filed 2026-02-17 | -$10.00M 10-K · filed 2026-02-17 | -$11.00M 10-K · filed 2024-02-20 |
| 2023-09-30 | $16.00M 10-Q · filed 2023-11-01 | $16.00M derived: sum of 2 quarters · filed 2023-11-01 | $16.00M 10-Q · filed 2023-11-01 | $16.00M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 derived: sum of 4 quarters · filed 2025-02-18 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | |||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |